Pharma antitrust dispute ‘must be arbitrated’, says US court
The intravenous drug Remicade drug is the subject of class action and patent disputes (Credit: iStock/aydinmutlu)
A US appeals court has upheld its ruling that an antitrust class action against US pharmaceutical conglomerate Johnson & Johnson over an alleged anticompetitive scheme to protect billion-dollar sales of an autoimmune drug must be arbitrated.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Subscribe now